Strategic Blueprint, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 848 filers reported holding GLAXOSMITHKLINE PLC in Q1 2019. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
Strategic Blueprint, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2021$2,000
-99.9%
51
-99.9%
0.00%
-100.0%
Q2 2020$1,680,000
+12.9%
41,185
+4.9%
0.59%
-31.9%
Q1 2020$1,488,000
-13.9%
39,272
+6.8%
0.87%
-26.8%
Q4 2019$1,728,000
+6.6%
36,776
-3.2%
1.19%
-2.7%
Q3 2019$1,621,000
+8.9%
37,978
+2.1%
1.22%
-3.8%
Q2 2019$1,488,000
+15.1%
37,183
+20.2%
1.27%
+8.1%
Q1 2019$1,293,00030,9321.17%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2019
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders